Search Within

Ellen Marlese Basu

  1. "Neuro-Oncology Service"
Formats
  1. Journal Article (23)
  2. Meeting Abstract (17)
  3. Correspondence (1)
Groups
  1. Neuro-Oncology Service (41)
  2. Neuroblastoma Service (41)
  3. Pediatrics, Department of (41)
  4. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (35)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (35)
  6. GSK Faculty (35)

More Groups

People
  1. Kim Kramer (37)
  2. Shakeel Modak (36)
  3. Brian Kushner (35)
  4. Nai-Kong Cheung (34)
  5. Stephen Roberts (30)
  6. Suzanne Wolden (15)

More People

Years
  1. 2025 (1)
  2. 2024 (5)
  3. 2023 (6)
  4. 2021 (1)
  5. 2020 (4)
  6. 2019 (2)

More Years

Publications
  1. Pediatric Blood and Cancer (10)
  2. Journal of Clinical Oncology (7)
  3. Cancer (4)
  4. International Journal of Cancer (4)
  5. Neuro-Oncology (4)
  6. Oncotarget (2)

More Publications

Publishers
  1. Wiley Periodicals, Inc (10)
  2. American Society of Clinical Oncology (7)
  3. John Wiley & Sons (4)
  4. Oxford University Press (4)
  5. Wiley Blackwell (4)
  6. Springer (3)

More Publishers

Results (41)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Adoptive immunotherapy with haploidentical natural killer cells and Anti-GD2 monoclonal antibody m3F8 for resistant neuroblastoma: Results of a phase I study
    Journal Article

    Modak, S.; Le Luduec, J. B.; Cheung, I. Y.; Goldman, D. A.; Ostrovnaya, I.; Doubrovina, E.; Basu, E.; Kushner, B. H.; Kramer, K.; Roberts, S. S.; more...
    OncoImmunology (2018)

    Fulltext@MSK | Save
  • Treatment and outcome of adult-onset neuroblastoma
    Journal Article

    Suzuki, M.; Kushner, B. H.; Kramer, K.; Basu, E. M.; Roberts, S. S.; Hammond, W. J.; LaQuaglia, M. P.; Wolden, S. L.; Cheung, N. K. V.; Modak, S.
    International Journal of Cancer (2018)

    Fulltext@MSK | Save
  • Safety and efficacy of intraventricular (131)I-labeled monoclonal antibody 8H9 targeting the surface glycoprotein B7-H3
    Meeting Abstract

    Kramer, K.; Kushner, B.; Modak, S.; Taskar, N. P.; Tomlinson, U.; Donzelli, M.; Wolden, S.; Zanzonico, P.; Humm, J.; Haque, S.; more...
    Neuro-Oncology (2018)

    Fulltext@MSK | Save
  • Safety and efficacy of intraventricular (131)I-labeled monoclonal antibody 8H9 targeting the surface glycoprotein B7-H3 in patients with CNS/LM disease
    Meeting Abstract

    Kramer, K.; Kushner, B.; Modak, S.; Pandit-Taskar, N.; Tomlinson, U.; Donzelli, M.; Wolden, S.; Zanzonico, P.; Humm, J.; Haque, S.; more...
    Neuro-Oncology (2017)

    Fulltext@MSK | Save
  • Safety and efficacy of intraventricular (131)I-labeled monoclonal antibody 8H9 targeting the surface glycoprotein B7-H3 in patients with CNS/LM disease
    Meeting Abstract

    Kramer, K.; Kushner, B.; Modak, S.; Pandit-Taskar, N.; Tomlinson, U.; Donzelli, M.; Wolden, S.; Zanzonico, P.; Humm, J.; Haque, S.; more...
    Neuro-Oncology (2017)

    Fulltext@MSK | Save
  • MYCN-amplified stage 2/3 neuroblastoma: Excellent survival in the era of anti-G(D2) immunotherapy
    Journal Article

    Kushner, B. H.; LaQuaglia, M. P.; Modak, S.; Wolden, S. L.; Basu, E. M.; Roberts, S. S.; Kramer, K.; Yataghene, K.; Cheung, I. Y.; Cheung, N. V.
    Oncotarget (2017)

    Fulltext@MSK | Save
  • A phase I/Ib trial targeting the Pi3k/Akt pathway using perifosine: Long-term progression-free survival of patients with resistant neuroblastoma
    Journal Article

    Kushner, B. H.; Cheung, N. K. V.; Modak, S.; Becher, O. J.; Basu, E. M.; Roberts, S. S.; Kramer, K.; Dunkel, I. J.
    International Journal of Cancer (2017)

    Fulltext@MSK | Save
  • Phase II study of the combination of bevacizumab plus irinotecan and temozolomide for relapsed or refractory neuroblastoma (NB)
    Meeting Abstract

    Modak, S.; Kushner, B. H.; Kramer, K.; Leyco, S.; Basu, E. M.; Roberts, S. S.; Cheung, N. K. V.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Event-free survival (EFS) and overall survival (OS) of MYCN-amplified stage 2/3 neuroblastoma with or without autologous stem-cell transplantation (ASCT)
    Meeting Abstract

    Kushner, B. H.; Modak, S.; LaQuaglia, M. P.; Wolden, S. L.; Basu, E. M.; Roberts, S. S.; Kramer, K.; Cheung, I. Y.; Cheung, N. K. V.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Lack of survival advantage with autologous stem-cell transplantation in high-risk neuroblastoma consolidated by anti-GD2 immunotherapy and isotretinoin
    Journal Article

    Kushner, B. H.; Ostrovnaya, I.; Cheung, I. Y.; Kuk, D.; Modak, S.; Kramer, K.; Roberts, S. S.; Basu, E. M.; Yataghene, K.; Cheung, N. K. V.
    Oncotarget (2016)

    Fulltext@MSK | Save